XML 17 R6.htm IDEA: XBRL DOCUMENT v3.21.1
Condensed Consolidated Statements of Cash Flows (Unaudited) - USD ($)
 3 Months Ended 12 Months Ended
Mar. 31, 2021
Mar. 31, 2020
Dec. 31, 2020
CASH FLOW FROM OPERATING ACTIVITIES:      
Net loss $ (851,431) $ (3,370,282)  
Adjustments to reconcile net loss to cash used in operating activities:      
Depreciation 25,115 19,912  
Amortization of intangible assets 54,016 7,164  
Amortization of debt discount 18,000 218,061  
Amortization of capitalized contract costs 22,989 36,679  
Amortization of debt issuance costs 878,398  
Loss on extinguishment of debt 499,076  
Amortization of beneficial conversion feature 413,687  
Interest expense capitalized to note payable 40,995  
Operating leases right-of-use assets 57,119 46,009  
Stock based directors’ fees 7,510  
Share based compensation for employees and consultants 133,638 512,719  
Change in assets and liabilities:      
Accounts receivable (884,199) 5,707  
Due from factor 10,645 (19,729)  
Capitalized contract costs (27,893) (13,659)  
Inventory (269,500) 31,408  
Resalable software license rights 2,521 5,028  
Prepaid expenses and other (1,404,654) (58,175)  
Accounts payable 65,165 (227,572)  
Accrued liabilities 27,465 (57,777)  
Deferred revenue (128,107) 54,133  
Operating lease liabilities (56,958) (44,587)  
Net cash used in operating activities (3,198,559) (1,022,805)  
CASH FLOW FROM INVESTING ACTIVITIES:      
Capital expenditures (13,307)  
Net cash used in investing activities (13,307)  
CASH FLOW FROM FINANCING ACTIVITIES      
Proceeds from issuance of convertible notes 283,000  
Costs to issue notes and common stock (2,709) (13,000)  
Proceeds from warrant exercise 1,458,000  
Repayments of note payable - PistolStar (250,000)  
Net repayments of loans payable to related parties (122,271)  
Net cash (used in) provided by financing activities (252,709) 1,605,729 $ 24,000,000
NET INCREASE (DECREASE) IN CASH AND CASH EQUIVALENTS (3,464,575) 582,924  
CASH AND CASH EQUIVALENTS, BEGINNING OF PERIOD 16,993,096 79,013 79,013
CASH AND CASH EQUIVALENTS, END OF PERIOD 13,528,521 661,937 $ 16,993,096
Cash paid for:      
Interest 18,000  
Noncash Investing and financing activities      
Deemed dividends related to down-round features 112,686  
Common Stock issued for loan commitment fees 132,500  
Conversion of convertible note payable to common stock 1,500,000  
Beneficial conversion feature $ 641,215